Validation of the European Spondylarthropathy Study Group and B. Amor criteria for spondylarthropathies in Lebanon.
Validation of the European Spondylarthropathy Study Group and B. Amor criteria for spondylarthropathies in Lebanon.
复制标题
欧洲脊柱关节病研究组和黎巴嫩脊柱关节病 B. Amor 标准的验证。
DOI：
--
复制
发表时间：
1997
期刊：
影响因子：
--
通讯作者：
M. AbiSaab
中科院分区：
文献类型：
--
作者：
R. Baddoura;H. Awada;J. Okais;T. Habis;S. Attoui;M. AbiSaab
目标
OBJECTIVES
1) To validate European Spondylarthropathy Study Group (ESSG) and B. Amor's criteria for spondylarthropathies in Lebanon. 2) To evaluate the frequency of spondylarthropathies in rheumatological practice in Lebanon.
PATIENTS AND METHODS
Cases of definite and probable spondylarthropathy were diagnosed based on the clinical judgement of participating rheumatologists, without reference to the two criteria sets under study. The first two patients without spondylarthropathy seen after each spondylarthropathy case were included into the control group. Criteria in the ESSG and B. Amor sets were looked for in the patient and control groups. The frequency of spondylarthropathy meeting each criteria set was determined.
RESULTS
Of the 841 patients evaluated during the study period, 68 met B. Amor's criteria and 72 met ESSG criteria. There were 29 cases of ankylosing spondylitis (40.3%), ten of peripheral psoriatic arthritis (13.8%), two of reactive arthritis (2.8%), two of enteropathic arthropathy (2.8%), and 29 of undifferentiated spondylarthropathy (40.3%). In the definite spondylarthropathy group, sensitivity and specificity were 77.19% and 97.55% for B. Amor's criteria versus 91.23% and 100% for ESSG criteria. The frequency of spondylarthropathy was 8.1% (95% confidence interval [CI], 6.3-9.9) or 8.56% (CI 6.6-10.5) according to B. Amor and ESSG criteria, respectively.
CONCLUSION
Our data validate both criteria sets in the Lebanese population, demonstrating that they are useful in populations that are genetically different from the European populations used to develop them. Spondyloarthropathy is the most common in our rheumatology practice.